Prime Medicine Inc (NAS:PRME)
$ 3.175 +0.065 (+2.09%) Market Cap: 573.46 Mil Enterprise Value: 552.48 Mil PE Ratio: 0 PB Ratio: 7.47 GF Score: 25/100

Prime Medicine Inc Annual Shareholders Meeting Transcript

Jun 05, 2026 / 06:00PM GMT
Release Date Price: $3.06 (-11.82%)
Operator

Hello and welcome to the 2026 Virtual Annual Meeting of Prime Medicine. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the Annual Meeting interface.

I would like to turn the meeting over to Allan Reine, the Chairperson of the Annual Meeting. Dr. Reine, you may begin.

Allan Reine
Prime Medicine, Inc - Chief Executive Officer, Director

Good afternoon, everyone. My name is Allan Reine, Chief Executive Officer and Director of Prime Medicine. The meeting is now called to order. It is a pleasure to welcome our stockholders to the annual meeting of Prime Medicine.

This meeting is being held in accordance with the company's bylaws and Delaware law. Our meeting will consist of the formal business at hand, which is described in our notices of internet availability of proxy materials, a copy of which was mailed on or about. April 23, 2026, to all our stockholders of record as of the close of business on April 9, 2026, and the proxy statement filed with the SEC.

During the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot